Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery

• Published in: Pharmaceutics 2021-11, Vol.13 (12), p.1985
• Main Authors: Broesder, Annemarie, Bircan, Said Y, de Waard, Anneko B, Eissens, Anko C, Frijlink, Henderik W, Hinrichs, Wouter L J
• Format: Article
• Language: English
• Subjects: Caffeine; Colon; ColoPulse; Drug delivery systems; Drug dosages; Ethanol; extrusion–spheronization; film coating; ileo-colonic targeting; pan coating; Plasma; Small intestine; Sodium
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics13121985

The ColoPulse coating is a pH-dependent coating that can be used to target drug release to the ileo-colonic region. ColoPulse coated tablets and capsules have demonstrated their targeting capabilities in vivo in more than 100 volunteers and patients. However, so far the ColoPulse coating has not been used for multi-particulate pellet formulations. The sulfasalazine-caffeine method can be used to confirm ileo-colonic drug delivery in vivo. Caffeine serves as a release marker in this method, while sulfasalazine serves as a marker for colonic arrival. In this study, extrusion-spheronization was used to produce microcrystalline cellulose based pellets containing both caffeine and sulfasalazine. Dissolution tests revealed that a superdisintegrant, i.e., croscarmellose sodium or sodium starch glycolate, should be incorporated in the formulation to achieve acceptable release profiles for both sulfasalazine and caffeine. However, acceptable release profiles were only obtained when the pelletizing liquid consisted of ethanol/water 1/1 ( ) but not with pure water. This phenomenon was ascribed to the differences in the degree of swelling of the superdisintegrant in the pelletizing liquid during the granulation process. The pellets were coated with the ColoPulse coating and showed the desired pH-dependent pulsatile release profile in vitro. In future clinical studies, ileo-colonic targeting should be verified.